Skip to main content
. 2022 Jan 19;14(3):494. doi: 10.3390/cancers14030494

Figure 8.

Figure 8

(A) VIP scores that summarize the contribution of the evaluated inflammasome components to discriminate patients with SPA <−1.65. (B) Heatmap obtained with the expression levels of the components that better discriminate between patients with SPA <−1.65 and >−1.65 using bioinformatics analysis of clustering.